Cargando…
The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality
The efficacy of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19 was contentious. In this randomized control double-blind clinical trial, asymptomatic individuals with direct contact with laboratory-confirmed COVID-19 cases were randomized into PEP/HCQ (N = ...
Autores principales: | Dhibar, Deba Prasad, Arora, Navneet, Chaudhary, Deepak, Prakash, Ajay, Medhi, Bikash, Singla, Neeraj, Mohindra, Ritin, Suri, Vikas, Bhalla, Ashish, Sharma, Navneet, Singh, Mini P., Lakshmi, P. V. M., Goyal, Kapil, Ghosh, Arnab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825075/ https://www.ncbi.nlm.nih.gov/pubmed/36611040 http://dx.doi.org/10.1038/s41598-022-26053-w |
Ejemplares similares
-
Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study
por: Dhibar, Deba Prasad, et al.
Publicado: (2020) -
Clinical spectrum and outcome of patients visiting coronavirus screening centre in North India and clinical predictors for COVID-19
por: Singla, Neeraj, et al.
Publicado: (2021) -
Hydroxychloroquine (HCQ): real treatment or false hope?
por: El Bakkouri, Karim
Publicado: (2021) -
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
por: Garg, Shivani, et al.
Publicado: (2023) -
Clinical, Biochemical Characteristics and Hospital Outcome of Acute Intermittent Porphyria Patients: A Descriptive Study from North India
por: Kumar, Susheel, et al.
Publicado: (2017)